| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3927516 | European Urology | 2010 | 7 Pages |
Abstract
PCA3 as a first-line screening test shows improvement of the performance characteristics and identification of serious disease compared with PSA in this prescreened population.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Monique J. Roobol, Fritz H. Schröder, Pim van Leeuwen, Tineke Wolters, Roderick C.N. van den Bergh, Geert J.L.H. van Leenders, Daphne Hessels,